Peer-influenced content. Sources you trust. No registration required. This is HCN.
The survey demonstrates the rapid adoption of telemedicine, with 48% of physicians respondents reporting that they are now treating patients through telemedicine, but the pandemic is also creating significant disruption as some physicians are furloughed and others consider practice changes.
Allergy & Immunology July 20th 2020
Healthgrades for Professionals
Thanks to the Internet, more consumers than ever before are exposed to misleading, fraudulent medical hoaxes. These are five of the major culprits out there. Combat the misinformation for your patients and replace it with trustworthy, evidence-based research.
Allergy & Immunology July 13th 2020
Published on the AUA website and developed by a panel of experts from these three groups as well as representation from the American Society of Clinical Oncology (ASCO) and a patient advocate, 38 recommendations are listed across the care continuum of advanced disease.
Geriatrics July 6th 2020
According to the results of a single-arm, multicenter phase 2 trial in JAMA Oncology, low-dose erlotinib may be a safe and effective option for frail or elderly patients with EGFR mutation-positive NSCLC.
Geriatrics June 29th 2020
As a result of COVID-19, many physicians had to provide telemedicine services in a matter of weeks, if not days. A major accomplishment, for sure. But are you getting paid for your hard work? Read on to find out how you can ensure you are being compensated for the work you’ve been doing.
Allergy & Immunology June 22nd 2020
After tobacco use and excess body weight, alcohol consumption is the third major modifiable cancer risk factor. In its latest guidelines, the American Cancer Society has tightened its grip on its recommendations, basically telling people not to drink alcohol at all if they want to prevent cancer risk.
Family Medicine/General Practice June 15th 2020